D two and four-vessels global ischemia models. Arch Trauma Res. 2013;2(3):124?. 32. Sutherland BA, Neuhaus AA, Couch Y, Balami JS, DeLuca GC, Hadley G et al. The transient intraluminal filament middle cerebral artery occlusion model as a model of endovascular thrombectomy in stroke. J Cerebral Blood Flow. 2016;36(2):363-9. 33. Shahjouei S, Cai PY, Ansari S, Sharififar S, Azari H, Ganji S, et al. Middle Cerebral Artery Occlusion Model of Stroke in Rodents. J Vasc Interv Neurol. 2016;8(5):1. 34. Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 1999;22(9):391?. 35. Mattson M, Duan W, Pedersen W, Culmsee C. Neurodegenerative disorders and ischemic brain diseases. Apoptosis. 2001;6(1-2):69?1. 36. Butler TL, Kassed CA, Sanberg PR, Willing AE, Pennypacker KR. Neurodegeneration in the rat hippocampus and striatum after middle cerebral artery occlusion. Brain Res. 2002;929(2):252?0.Mokhtari et al. DARU Journal of Pharmaceutical Sciences (2017) 25:Page 11 of37. Erfani S, Khaksari M, Oryan S, Shamsaei N, Aboutaleb N, Nikbakht F, et al. Visfatin reduces hippocampal CA1 cells death and improves learning and memory deficits after transient global ischemia/reperfusion. Neuropeptides. 2015;49:63?. 38. Mao Y, Yang G-Y, Zhou L-F, Stern JD, Betz AL. Focal cerebral ischemia in the mouse: description of a model and effects of permanent and temporary occlusion. Mol Brain Res. 1999;63(2):366?0. 39. Hill WD, Hess DC, Carroll JE, Wakade CG, Howard EF, Chen Q, et al. The NF-B inhibitor diethyldithiocarbamate (DDTC) increases brain cell death in a transient middle cerebral artery occlusion model of ischemia. Brain Res Bull. 2001;55(3):375?6. 40. Ambrogini P, Cuppini R, Ferri P, Mancini C, Ciaroni S, Voci A, et al. Thyroid hormones affect neurogenesis in the dentate gyrus of adult rat. Neuroendocrinology. 2005;81(4):244?3. 41. Gf L, Raj A, Alfama G, Turque N, Hassani Z, Alegria-Prevot O, et al. Adult neural stem cell cycling in vivo requires thyroid BMS-791325 web hormone and its alpha receptor. FASEB J. 2005;19:863?. 42. Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med. 2001;344(7):501?. 43. L sse H-G, Roskoden T, Linke R, Otten U, Heese K, Schwegler H. Modulation of mRNA expression of the neurotrophins of the nerve growth factor family and their receptors in the septum and hippocampus of rats after transient postnatal thyroxine treatment I. Expression of nerve growth factor, brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin 4 mRNA. Exp Brain Res. 1998;119(1):1?. 44. Campolo M, Genovese T, Impellizzeri D, Ahmad A, Cornelius C, Cuzzocrea S, et al. Post-ischemic thyroid hormone treatment in a rat model of acute stroke. FASEB J. 2013;27(1):662.17. 45. Camboni D, Roskoden T, Schwegler H. Effect of early thyroxine treatment on brain-derived neurotrophic factor mRNA expression and protein amount in the rat medial septum/diagonal band of Broca. Neurosci Let. 2003;350(3):141?. 46. Vaidya V, Castro M, Pei Q, Sprakes M, Grahame-Smith D. Influence of thyroid hormone on 5-HT 1A and 5-HT 2A receptor-mediated regulation of hippocampal BDNF mRNA expression. Neuropharmacology. 2001;40(1):48?6. 47. Koibuchi N, Fukuda H, Chin WW. Promoter-Specific PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/26240184 Regulation of the BrainDerived Neurotropic Factor Gene by Thyroid Hormone in the Developing Rat Cerebellum 1. Endocrinology. 1999;140(9):3955?1. 48. Giordano T, Pan JB, Casuto D, Watanabe S, Arneric SP. Thyroid hormone regulation of NGF, NT-3 and.
